Thursday, April 27, 2017

FDA Law Blog: Apotex Petitons FDA on Biosimilar NEULASTA; Wants Comparative Clinical Efficacy Studies in at Least One Patient Population Posted: 26 Apr 2017 07:01 PM PDT By Sara W. Koblitz –

No comments:

Post a Comment